drugset
drugset / Trial / NCT05554679

Maternal and Fetal Outcome With Metformin Therapy for Obese Pregnant Women .

NCT05554679 ↗

Phase 4 Terminated 178 enrolled Assiut University
RandomizedParallel-groupOpen-labelPrevention

Summary

To evaluate the role of metformin in pregnant women with obesity (BMI above 30) , on maternal and infant outcome.

Timeline

Start
2021-02-01
Primary completion
2022-12-30
Completion
2023-07-11

Outcome

Outcome not reported

Stopped (Business): “financial issues”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule — Oral

Indications

No indication recorded.